Dec 02, 2021 / 07:00AM GMT
Lutz Hegemann - Novartis AG - Group Head of Corporate Affairs & Global Health
(technical difficulty)
social and governance considerations into our core business because we believe that taking ESG at the heart of our business helps reduce risk, it drives value and impact. And fundamentally, it's the right thing to do for humanity. We believe that it starts with a very clear purpose, which we have defined together with our associates and with external stakeholders, and we see our mandates to innovate with new medicines and to make them available to as many patients as possible. And we have validated this also as an external expectation from stakeholders over and over again, for instance, through our materiality analysis where we just completed the most recent analysis a few months ago and which I'm sure will be subject of discussion throughout the day.
While articulating this intent of ESG business integration, it's relatively easy to do, doing it is certainly hard work and very continuous efforts. And here at Novartis, we certainly don't claim [this] on a learning journey, trying new
Novartis AG at Novartis Co-Creating Impact Summit (Virtual) - Morning Session Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers